Home › Biliary Liver Cirrhosis › New York
Biliary Liver Cirrhosis clinical trials in New York
3 studies for Biliary Liver Cirrhosis are looking for participants at sites in New York.
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- Northwell Health Center for Liver Disease and Transplantation, Manhasset
- NYU Langone Health, New York
- New York-Presbyterian/Weill Cornell Medical Center, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06051617A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
- Northwell Health Inc, Center for Liver Disease and Transplantation, Manhasset
RecruitingObservational study
All ages · All sexes · Updated Aug 31, 2026 · NCT06447168A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
- NYU Langone Gastroenterology and Hepatology Associates, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT06016842From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.